Nov 22, 2025
How do Memoblast trial results compare to alternative treatments for the same indications?
Mesoblast’s Mesenchymal Precursor Cell (MPC) programs — including intradiscal rexlemestrocel-L (MPC+HA) for chronic low back pain and systemic remestemcel‑L/rexlemestrocel‑L investigations in heart fa...